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Abstract 19 
Shiga toxin-producing E. coli (STEC) O80:H2 is an uncommon hybrid pathotype that has 20 
recently emerged in France. We analysed 18 STEC O80:H2 isolated from humans in 21 
Switzerland during 2010-2017. All isolates carried stx2a or stx2d, the rare eae variant eae-ξ 22 
and at least seven virulence genes associated with pS88, a plasmid that is found in 23 
extraintestinal pathogenic E. coli (ExPEC). Whole genome sequencing (WGS) identified 24 
additional chromosomal extraintestinal virulence genes encoding for type 1 fimbria (fimA, 25 
fimC and fimH), aerobactin (iuc/iutA) and afimbrial adhesins (afaA/C/D/E-VIII). Core 26 
genome multi-locus sequence typing (cgMLST) detected two closely related but distinct 27 
subclusters with different stx2 and iuc/iutA genotypes. All isolates were multidrug resistant 28 
(MDR), but susceptible to third generation cephalosporins and azithromycin. STEC/ExPEC 29 
hybrid pathotypes such as STEC O80:H2 represent a therapeutical challenge in the event of 30 
extraintestinal infection.  31 
 32 
 33 
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1. Introduction 43 
Shiga toxin (Stx)-producing Escherichia coli (STEC) are important foodborne pathogens and 44 
responsible for gastrointestinal illnesses which may involve non-bloody or bloody diarrhea, 45 
haemorrhagic colitis (HC), and the haemolytic uremic syndrome (HUS) (Karch et al., 2005). 46 
The primary virulence trait of STEC is Stx, which includes two major groups, Stx1 and Stx2, 47 
whereby Stx2a, Stx2c and Stx2d are mainly associated with severe disease (Fuller et al., 2011). 48 
An additional virulence trait that may be present in STEC includes intimin, an outer membrane 49 
protein which is responsible for the ability to form attaching and effacing lesions in the human 50 
intestinal mucosa (Jerse et al. 1990). Intimin is encoded by the chromosomal gene eae, which 51 
is part of a pathogenicity island termed the locus for enterocyte effacement, LEE (Kaper et al. 52 
2004). Differentiation of eae subtypes represents a valuable tool for typing STEC in the clinical 53 
setting as well as for epidemiological studies. At present, 30 distinct eae subtypes have been 54 
identified and appended by lower case Greek letters and Roman numbers α1, α2, α8, β1, β2, 55 
β3, γ1, γ2, ε1, ε2, ε3, ε4, ζ, ζ3, η, η2, θ, ι1, ι2, κ, λ, µ, ν, ξ, ο, π, ρ, σ, τ, and υ, respectively 56 
(Ooka et al. 2012). E. coli O157:H7 is reportedly the most common STEC serotype in the 57 
European Union and in Switzerland, nonetheless, non-O157 STEC serogroups, in particular 58 
O26, O91, O103, O111, O121 and O145, are also frequently detected (EFSA, 2017; Fierz et 59 
al. 2007). By contrast, reports of STEC O80:H2 strains are rare. However, this pathotype has 60 
recently emerged in France and is associated with severe cases of HUS, as well as HUS 61 
associated with bacteremia (Mariani-Kurkdjian et al., 2014; Soysal et al., 2016). A further case 62 
of STEC O80:H2 induced lethal complication of HUS was very recently reported in the 63 
Netherlands (Wijnsma et al., 2017). This unusual STEC serotype features the rare eae-ξ (xi), 64 
and genetic determinants encoded by the pS88 plasmid which is associated with extraintestinal-65 
virulence pathogenic E. coli (ExPEC) (Peigne et al., 2009).   66 
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This study aimed to examine the molecular characteristics of 18 human STEC O80:H2 67 
isolates collected during 2010-2017 at the National Centre for Enteropathogenic Bacteria and 68 
Listeria (NENT) in Zürich, Switzerland, using conventional PCR methods and whole genome 69 
sequencing. Moreover, the genetic relatedness of the strains was determined using core 70 
genome multilocus sequence typing. 71 
 72 
2. Materials and Methods 73 
2.1. Bacterial strains 74 
For this study, we analysed 18 STEC O80:H2 human isolates received between 2010 and 75 
2017 at the NENT in Zürich, Switzerland. Ten strains (55.6%) were from female, and eight 76 
(44.4%) from male patients. The median age was 28 years (range <1 – 81 years). Six (33.3%) 77 
strains were isolated from patients ≤5 years of age. Twelve (66.6%) of the infections 78 
occurred during the summer–early autumn season. The majority (n=13, 72.2%) of the cases 79 
were registered in the western parts of Switzerland that share borders with the high-incidence 80 
regions of France (Soysal et al., 2016). Aggregate clinical data was attainable for 10 81 
patients. Thereof, one (10%) developed HUS, and four (40%) were hospitalised. 82 
 83 
2.2. Ethics statement 84 
All the clinical isolates were collected from stool samples in the course of diagnostic 85 
procedures and were processed at the NENT. This study was approved by the local ethics 86 
committee of Zürich (BASEC-Nr.Req-2016-00374). 87 
 88 	  89 
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2.3. Serotyping 90 
The O80 serogroup was determined by O80-specific PCR using primers and conditions 91 
described previously (Soysal et al., 2016). The H2 type was identified by PCR targeting the 92 
flicH2 gene with primers described elsewhere (Alonso et al., 2017). 93 
 94 
2.4. Detection of virulence genes 95 
The presence of stx genes was initially determined by real-time PCR (LightCycler 96 
R 2.0 Instrument, Roche Diagnostics Corporation, Indianapolis, IN, USA) (EURL, 2013a). 97 
PCR-based identification of stx1 and stx2 subtypes was carried out as described in a previous 98 
study (Scheutz et al., 2012). The presence of eae and the identification of the eae-ξ variant 99 
was verified using methods described previously (Blanco et al., 2005; EURL, 2013a). The 100 
strains were further screened by PCR for the presence of hlyA encoding enterohemolysin 101 
(Schmidt et al., 1995), iha, encoding an iron acquisition protein (Schmidt et al., 2001), the 102 
subtilase cytotoxin gene, subAB (Funk et al., 2013), ipaH, characteristic for enteroinvasive E. 103 
coli (EIEC)  (Persson et al., 2007), aggR coding for a transcriptional regulator in 104 
enteroaggregative E. coli (EAEC) (EURL, 2013b), and the pS88 related genes sitA, eitB, cia, 105 
iss, iucC, iroN, hlyF, etsC, cvaA, and ompTp (Peigne et al., 2009). 106 
 107 
2.5. Multi locus sequence typing (MLST) 108 
MLST was performed by PCR amplification of internal fragments of seven housekeeping 109 
genes (adk, fumC, gyrB, icdF, mdh, purA, and recA) (Wirth et al., 2006).  Custom sequencing 110 
of the alleles was performed by Microsynth (Balgach, Switzerland). Sequence types (STs) 111 
were assigned in accordance with the E. coli MLST database website 112 
(https://pubmlst.org/databases.shtml). 113 
 114 
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2.6. Whole genome sequencing (WGS) and in silico analysis 115 
Whole genome sequencing was performed using a MiSeq Illumina platform with 2x 300nt 116 
pair-end sequencing as previously described (Meinel et al., 2014). Reads were de novo 117 
assembled using SPAdes (version 3.11.1) (Bankevich et al., 2012) and the resulting assembly 118 
was polished using Pilon (version 1.22) (Walker et al., 2014). Mean coverage of the 119 
sequenced genomes was more than 50-fold.  120 
We carried out in silico genome analysis using the virulence factor database (VFDB) (Chen 121 
et al., 2005), to determine the presence of virulence genes. Furthermore, we performed a core 122 
genome MLST to assess the genetic relatedness among the isolates. The core genome MLST 123 
is based on ATCC 25922 and was generated using Ridom SeqSphere Software (version 4.1.9, 124 
available at http://www.ridom.de/seqsphere/cgmlst/).  125 
Antimicrobial resistance genes were searched for using the RGI tool (version 3.2.1) that is 126 
based on the CARD database (Jia et al., 2017).  127 
 128 
2.7. Antimicrobial susceptibility testing 129 
Antimicrobial susceptibility testing was performed using the disk-diffusion method and the 130 
antibiotics ampicillin (AM), amoxicillin-clavulanic acid (AMC), cefazolin (CZ), cefotaxime 131 
(CTX), cefepime (FEP), nalidixic acid (NA), ciprofloxacin (CIP), gentamicin (GM), 132 
kanamycin (K), streptomycin (S), sulfamethoxazole/trimethoprim (SXT), fosfomycin (FOS), 133 
azithromycin (AZM), nitrofurantoin (F/M), chloramphenicol (C) and tetracycline (T) (Becton 134 
Dickinson, Heidelberg, Germany). Results were interpreted according to Clinical and 135 
Laboratory Standards Institute (CLSI) performance standards (CLSI, 2016). For 136 
azithromycin, an inhibition zone diameter of ≤ 12 mm was considered resistant. Multidrug 137 
resistance (MDR) was defined as resistance to three or more classes of antimicrobials, 138 
counting ß-lactams as one class. 139 
 7 
 140 
3. Results  141 
3.1 Detection of virulence genes 142 
Of the 18 STEC O80 strains, nine (50%) harboured stx2a, and 9 further (50%) stx2d (Table). 143 
All isolates harboured the rare variant of the intimin gene, eae-ξ. Fourteen isolates encoded 144 
hlyA, and 13 iha, respectively (Table). All 18 isolates contained at least seven pS88-related 145 
virulence genes (Table). 146 
In silico genome analysis revealed that all 18 isolates carried fimbria associated genes fimA, 147 
fimC and fimH (Table). Further, 9 isolates contained the aerobactin encoding genes iucA, 148 
iucB, iucC, and iutA. Finally, afa-VIII genes encoding for afimbrial adhesins were detected in 149 
three isolates (Table). 150 
 151 
3.2 Clonal relationship among the STEC O80:H2 isolates 152 
MLST by PCR assigned all 18 isolates to ST301. Using core genome data, we identified two 153 
distinct but highly related clusters of the STEC O80:H2-ST301 strains (Table and Figure). 154 
Cluster 1 consisted of nine isolates that harboured stx2a (Figure). Cluster 2 contained nine 155 
isolates that contained stx2d (Figure). Furthermore, cluster 2 consisted of the isolates 156 
containing the iucA, iucB, iucC, and iutA genes, and contained the three isolates carrying afa-157 
VIII genes (Table and Figure). Finally, in contrast to isolates from cluster 1, all isolates 158 
belonging to cluster 2 harboured pS88 associated etsC (Table).  159 
 160 
3.3. Antimicrobial susceptibility 161 
Antimicrobial drug susceptibility testing revealed that all strains were MDR, i.e., resistant to 162 
three or more classes of antimicrobials, counting ß-lactams as one class (Supplementary 163 
Material Table 1). Rates of resistance were 100% for ampicillin, streptomycin, and 164 
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sulfamethoxazole/trimethoprim. Fourteen (77.8%) of the isolates were resistant to nalidixic 165 
acid, 13 (72.2%) to tetracycline, and nine (50%, all belonging to cgMLST cluster 2) to 166 
chloramphenicol. None of the isolates were resistant to third-generation cephalosporins, 167 
ciprofloxacin, fosfomycin, azithromycin or nitrofurantoin (Supplementary Material Table 1). 168 
In correlation to the phenotypic profiles, the genotypical presence of blaTEM-1 and aph(6)-Id was 169 
confirmed in silico for all isolates, whereas  sul-1, sul-2, genes were detected in 16 isolates 170 
(Supplementary Material Table 2). The RGI resistance gene tool did not detect any genes that 171 
predict resistance to tetracycline or chloramphenicol. 172 
 173 
3.4. GenBank accession numbers 174 
DNA sequences are available under the accession numbers PYSA00000000 to 175 
PYSF00000000, and PYRO00000000 to PYRZ00000000, respectively. 176 
 177 
4. Discussion 178 
In this study, we characterised 18 STEC O80:H2 isolates that were collected from humans 179 
during 2010-2017 in Switzerland. This rare serotype has been described as an emerging 180 
STEC in eastern regions of France, and the demographic characteristics of the patients in this 181 
study are suggestive of a possible common source or route of infection. However, the source 182 
of this serotype has so far not been identified (Soysal et al., 2016).  183 
STEC O80:H2 is associated with high extraintestinal virulence potential, due to the presence 184 
of virulence genes encoded on plasmid pS88. This plasmid was first detected in neonatal 185 
meningitis E. coli (NMEC) O45:H7 ST95, a major etiological agent of meningitis and 186 
urosepsis in infants in France (Bonacorsi et al., 2003). The pS88 sequence comprises several 187 
virulence regions homologous to plasmids pAPEC-O2-ColV and pAPEC-O1-ColBM from 188 
avian pathogenic E. coli (APEC) O2:K1 and O1:K1, strains that cause colibacillosis in 189 
 9 
chicken (Johnson et al., 2006a; Johnson et al., 2006b). Peigne et al. (2009) have demonstrated 190 
that this plasmid sustains high level bacteremia in the neonatal rat model and that pS88-like 191 
plasmids are widely distributed among MNEC clones, uropathogenic E. coli strains (UPEC), 192 
and avian pathogenic E. coli strains (APEC), including E. coli O18, O1, O2 and O83 and E. 193 
coli belonging mostly to ST95. By contrast, STEC O80:H2 appears so far to be the only 194 
instance of pS88 found among E. coli belonging to ST 301. Nevertheless, within ST301 a 195 
number of further E. coli serogroups type have been registered in the EcMLST databank and 196 
described in the literature, including an STEC O4:H– strain from diarrheic calves (Wieler et 197 
al., 1996), an E. coli O5 strain from a human infection (Gangiredla et al., 2017), NMEC O7 198 
(Peigne et al., 2009), clinical isolates E. coli O132:H2 and O55:H9 (Chattaway et al., 2017), 199 
STEC O180:H2 (Joensen et al., 2014), and E. coli O186 (Weimer, 2017). Whether any of 200 
these strains harbour pS88, and whether ST301 serogroups represent a particular genetic 201 
background for the acquisition of pS88-like plasmids remains to be elucidated.  202 
Moreover, it remains unclear to what extent pS88 may be involved in the pathogenicity of 203 
other STEC/ExPEC strains described previously. Such hybrids predominantly include 204 
UPEC/STEC hybrid strains such as the urovirulent O2:H6 ST141 (Bielaszewska et al., 2014), 205 
strains involved in HUS associated with urinary tract infections (UTI), including O157:H7, 206 
O17:H18, O103:H2, O174:H2, O145:H28, and O5:H–, some of which lacked identifiable 207 
uropathogenic virulence factors such as papA (Starr et al., 1998). STEC/ExPEC strains 208 
involved in bacteremia have been described for STEC O128ab:H2 (Buvens et al., 2013), 209 
O157:H2 (Chiurchiu et al., 2003), and O138:H– (Nguyen et al., 2007), however, 210 
characterisations of the genetic factors involved in extraintestinal pathogenicity are lacking.  211 
In addition to pS88, the STEC O80:H2 isolates in this study harboured further genes 212 
implicated in extraintestinal virulence. All isolates carried fimA, fimC and fimH, genes 213 
involved in biosynthesis of type 1 fimbria which are crucial for E. coli adhesion to epithelial 214 
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host cells as well as intracellular survival in phagocytes (Avalos Vizcarra et al., 2016). 215 
Furthermore, some of isolates containing the iucA, iucB, iucC, and iutA. These genes are 216 
involved in the biosynthesis of aerobactin, an iron uptake system that is associated with 217 
pathogenesis in extraintestinal E. coli strains and frequently present in EAEC clinical 218 
isolates, including the 2011 hybrid STEC/EAEC O104:H4 outbreak strain in Germany 219 
(Garcia-Angulo et al., 2013). A minority of the isolates carried afa-VIII genes encoding for 220 
afimbrial adhesins, which are present in both diarrheal and uropathogenic E. coli strains and 221 
also widespread among bovine pathogenic E. coli strains associated with diarrhoea and 222 
septicaemia (Antão et al., 2009). Notably, EPEC O80:H2 has recently been identified as an 223 
emerging pathogen in young calves and could be a precursor of STEC O80:H2 (Thiry et al., 224 
2017). Further characterisation of these isolates would be desirable in order to establish any 225 
common virulence traits between human and calf strains and to attempt an identification the 226 
source of STEC O80:H2. 227 
Taken together, our findings provide further evidence for the high pathogenicity and the 228 
extraordinary hybrid STEC/ExPEC characteristics which distinguishes STEC O80:H2 from 229 
other STEC serotypes. 230 
Although the strains in this study are closely related, cgMLST indicated a trend of subclonal 231 
divergence into distinct clusters with different virulence genotypes. While both clusters 1 and 232 
2 include strains carrying stx2 variants associated with severe disease (stx2a or stx2d), and 233 
genes for type 1 fimbria,  cluster 2 comprises strains with potentially higher extraintestinal 234 
virulence due to the additional virulence gene etsC encoded on pS88, the presence of 235 
aerobactin genes iuc/iutA, and in some cluster 2 isolates, the afimbrial adhesion genes 236 
afaA/C/D/E-VIII. These data suggest a genetic plasticity of STEC O80 regarding the 237 
acquisition of extraintestinal virulence factors. Notably, as opposed to the STEC O80:H2 238 
strains isolated in France (Soysal et al., 2016), none of the strains from this study harboured 239 
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stx2a/2d or stx2c/2d combinations. Moreover, in France, 74% of the STEC O80:H2 240 
harboured stx2c/2d and these accounted for the majority (56.9%) of the HUS cases. Among 241 
the 10 patients for whom clinical data was available in this study, one (10%) had HUS. The 242 
absence of the stx2c/2d genotype among the strains isolated in Switzerland may account for 243 
the lower prevalence of HUS. 244 
The clinical significance of extraintestinal virulence potential is exemplified by a case report 245 
of STEC O80:H2 associated bacteraemia (Mariani-Kurkdjian et al., 2014), raising the 246 
controversial question about antibiotic therapy during invasive STEC infection (Freedman et 247 
al., 2016). Antimicrobial drug susceptibility testing revealed that all strains were multidrug 248 
resistant (MDR), i.e., resistant to three or more classes of antimicrobials (Supplementary 249 
Material Table 1). Nevertheless, all isolates remained susceptible to third-generation 250 
cephalosporins and azithromycin. Our data therefore lend support to a therapeutical approach 251 
suggested by Soysal et al. (2016), which involves the combination of ceftriaxone with 252 
azithromycin to treat invasive infections of STECO80:H2. This hypervirulent, MDR hybrid 253 
pathotype exemplifies the need to monitor antimicrobial resistance in STEC as well as in 254 
other E. coli pathotypes. Finally, STEC O80:H2 may represent a threat in terms of public 255 
health. Surveillance and characterization of STEC isolates from severe cases of human 256 
disease using culture-based methods and WGS to supplement non-culture methods such as 257 
PCR based stx detection may improve the identification and source tracking of STEC 258 
O80:H2 infections. 259 
 260 
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Table: Genetic backgrounds of 18 Shiga toxin producing Escherichia coli serotype  446 
O80:H2-ST301, Switzerland, 2010-2017. 447 
 448 
 
Gene* 
 
Description of gene product 
No.(%) 
iisolates 
cgMLST1 
cluster 
EHEC associated markers 
   
stx2a Shiga toxin variant   9 (50) 1 
stx2d Shiga toxin variant   9 (50) 2 
eae- ξ Intimin variant (attaching and effacing protein) 18 (100) 1, 2 
hlyA Enterohemolysin 14 (77.8) 1, 2 
iha Iron acquisition protein 13 (72.2) 1, 2 
subAB Subtilase cytotoxin   0 (0) – 
EIEC associated marker 
   
ipaH Invasion plasmid antigen   0 (0) – 
EAEC associated marker 
   
aggR Transcriptional activator of aggregative adherence 
fimbria I 
  0 (0) – 
ExPEC associated markers 
   
sitA Periplasmic iron transport protein 18 (100) 1, 2 
eitB E. coli iron transport protein   0 (0) – 
cia Colicin Ia (bacteriocin) 17 (94.4) 1, 2 
iss Increased serum survival protein 18 (100) 1, 2 
iroC  ATP binding cassette 18 (100) 1, 2 
iroN  Salmochelin siderophore receptor 18 (100) 1, 2 
hlyF Hemolysin 18 (100) 1, 2 
etsC Putative type I secretion outer membrane protein   9 (50) 2 
cvaA Colicin V secretion protein 18 (100) 1, 2 
ompTp Outer membrane protease (omptin) 18 (100) 1, 2 
fimA Type-1 fimbrial protein 18 (100) 1, 2 
fimC Chaperone protein for the biogenesis of type 1 
fimbriae 
18 (100) 1, 2 
fimH Type 1 fimbrial adhesion 18 (100) 1, 2 
iucA Aerobactin siderophore biosynthesis enzyme   9 (50) 2 
iucB Aerobactin siderophore biosynthesis enzyme   9 (50) 2 
iucC Aerobactin siderophore biosynthesis enzyme   9 (50) 2 
iutA Outer membrane receptor for the ferric-siderophore 
complex 
  9 (50) 2 
afaA-VIII Afimbrial adhesion   3 (16.7) 2 
afaC-VIII Afimbrial adhesin usher protein   3 (16.7) 2 
afaD-VIII Afimbrial invasion   3 (16.7) 2 
afaE-VIII Afimbrial adhesion   3 (16.7) 2 
 449 
*EHEC, enterohemorrhagic E. coli; EIEC, enteroinvasive E. coli; EAEC, enteroaggregative 450 
E. coli; ExPEC, extraintestinal pathogenic E. coli. 451 
1core genome multilocus sequence type. 452 
 453 
 454 
455 
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Figure legend 456 
 457 
Figure: Core genome multilocus sequence type (cgMLST) based minimum spanning tree of 458 
18 human Shiga toxin producing Escherichia coli (STEC) O80:H2-ST301 isolates. Each 459 
circle contains the strain ID(s). Year of isolation is indicated in square brackets. Blue circles 460 
represent the stx-2a genotype, red circles indicate the stx2d genotype. Cluster 1 is shaded in 461 
light green. Cluster 2 is shaded in light yellow and contains strains with the iuc/iutA 462 
genotype. Strains within cluster 2 with the afa-VIII genotype are shaded in lime. The 463 
numbers on connecting lines represent the number of allelic differences between two strains.  464 
 465 
